Scenesse (afamelanotide acetate, Clinuvel Pharmaceuticals) is an FDA-approved subcutaneous implant for the reduction of phototoxicity in adult patients with erythropoietic protoporphyria
Physical Signs of Compromise In addition to changes in the solution, physical damage to the vial itself can be a warning sign
If youve been waiting to secure the protection against financial catastrophes you need, dont wait
In the STEP-1 trial published in The New England Journal of Medicine in 2021, once-weekly subcutaneous semaglutide at 2.4 mg produced a mean placebo-adjusted body weight reduction of 12.4% at 68 weeks in adults with overweight or obesity (Wilding et al., NEJM, 2021)
meanwhile, another RCT observed a reduction of epicardial adipose tissue (EAT) thickness and its glucose uptake in T2D patients with SGLT-2i treatment [24, 25]
The effects of probiotics supplementation on glycaemic control among adults with type 2 diabetes mellitus: a systematic review and meta-analysis of randomised clinical trials